Peter Blume-Jensen - President and CEO, Director at Acrivon Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
ACRV on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Peter Blume-Jensen since 7/15/2023

Holdings reported by Peter Blume-Jensen for Acrivon Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 2.56 M $21.4 M $8.36 May 14, 2024 Direct
Common Stock 318 K $2.66 M $8.36 May 14, 2024 Indirect

Transactions reported by Peter Blume-Jensen for Acrivon Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership